Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.
Journal
BMJ (Clinical research ed.)
ISSN: 1756-1833
Titre abrégé: BMJ
Pays: England
ID NLM: 8900488
Informations de publication
Date de publication:
31 05 2023
31 05 2023
Historique:
medline:
2
6
2023
pubmed:
1
6
2023
entrez:
31
5
2023
Statut:
epublish
Résumé
To compare the performance of a newly developed race-free kidney recipient specific glomerular filtration rate (GFR) equation with the three current main equations for measuring GFR in kidney transplant recipients. Development and validation study SETTING: 17 cohorts in Europe, the United States, and Australia (14 transplant centres, three clinical trials). 15 489 adults (3622 in development cohort (Necker, Saint Louis, and Toulouse hospitals, France), 11 867 in multiple external validation cohorts) who received kidney transplants between 1 January 2000 and 1 January 2021. The main outcome measure was GFR, measured according to local practice. Performance of the GFR equations was assessed using P The study included 15 489 participants, with 50 464 mGFR and eGFR values. The mean GFR was 53.18 mL/min/1.73m A new race-free kidney recipient specific GFR equation was developed and validated using multiple, large, international cohorts of kidney transplant recipients. The equation showed high accuracy and outperformed the race-free CKD-EPI 2021 equation that was developed in individuals with native kidneys. ClinicalTrials.gov NCT05229939.
Identifiants
pubmed: 37257905
doi: 10.1136/bmj-2022-073654
pmc: PMC10231444
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Banques de données
ClinicalTrials.gov
['NCT05229939']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e073654Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the French government through the National Research Agency and the European Union’s Horizon Europe programme; AL holds shares in Cibiltech, a company that develops software; No other relationships or activities that could appear to have influenced the submitted work.
Références
Transplant Proc. 2006 Dec;38(10):3517-9
pubmed: 17175319
Urology. 2022 Apr;162:42-48
pubmed: 33798557
Clin J Am Soc Nephrol. 2011 Jul;6(7):1774-80
pubmed: 21734093
J Am Soc Nephrol. 2016 Nov;27(11):3440-3446
pubmed: 27059513
Eur J Epidemiol. 2019 Aug;34(8):725-730
pubmed: 31161279
Nat Rev Nephrol. 2020 Jan;16(1):51-64
pubmed: 31527790
Ann Intern Med. 2021 Feb;174(2):183-191
pubmed: 33166224
JAMA. 2019 Jul 9;322(2):113-114
pubmed: 31169890
BMJ. 2013 Jan 29;346:f324
pubmed: 23360717
J Am Soc Nephrol. 2005 Nov;16(11):3437-44
pubmed: 16176999
Transplantation. 1995 Jun 27;59(12):1683-9
pubmed: 7604438
J Am Soc Nephrol. 2009 Nov;20(11):2305-13
pubmed: 19833901
J Am Soc Nephrol. 2013 Feb;24(2):320-7
pubmed: 23308016
JAMA. 2021 Feb 16;325(7):623-624
pubmed: 33492329
Transpl Int. 2009 Mar;22(3):323-31
pubmed: 19055616
Kidney Int. 2005 Jun;67(6):2089-100
pubmed: 15882252
BMJ. 2015 Jan 07;350:g7594
pubmed: 25569120
N Engl J Med. 2022 Apr 28;386(17):1669-1670
pubmed: 35476657
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
N Engl J Med. 2021 Nov 4;385(19):1737-1749
pubmed: 34554658
Am J Transplant. 2010 Mar;10(3):547-57
pubmed: 20415898
Clin J Am Soc Nephrol. 2011 Aug;6(8):1963-72
pubmed: 21737852
N Engl J Med. 2021 Nov 4;385(19):1750-1760
pubmed: 34554660
Kidney Int. 2018 Nov;94(5):964-973
pubmed: 30049474
Eur J Clin Pharmacol. 1985;28(5):537-41
pubmed: 4043198
N Engl J Med. 2021 Feb 4;384(5):396-399
pubmed: 33406354
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
J Pers Med. 2021 Sep 24;11(10):
pubmed: 34683089
Am J Kidney Dis. 2020 Jan;75(1):84-104
pubmed: 31473020
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Am J Kidney Dis. 2014 Sep;64(3):411-24
pubmed: 24840668
World J Nephrol. 2015 Jul 6;4(3):345-53
pubmed: 26167457
Am J Kidney Dis. 2022 Feb;79(2):268-288.e1
pubmed: 34563581
Dtsch Arztebl Int. 2010 Nov;107(44):776-82
pubmed: 21116397
Lancet Oncol. 2021 Sep;22(9):1333-1340
pubmed: 34399096
Am J Transplant. 2010 Mar;10(3):535-46
pubmed: 20415897
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Am J Kidney Dis. 2013 Jul;62(1):182-4
pubmed: 23608543
Eur J Epidemiol. 2009;24(12):733-6
pubmed: 19967429
Am J Kidney Dis. 2008 Jun;51(6):1005-15
pubmed: 18455847
Transplant Direct. 2017 Nov 08;3(12):e332
pubmed: 29536033
Kidney Int. 2021 Jan;99(1):186-197
pubmed: 32781106
BMJ. 2019 Sep 17;366:l4923
pubmed: 31530561
J Urol. 1975 Dec;114(6):802-8
pubmed: 1195454
Transplantation. 2013 May 27;95(10):1211-7
pubmed: 23511243
Kidney Int. 2022 May;101(5):856-858
pubmed: 35283173
JAMA Intern Med. 2020 May 1;180(5):793-795
pubmed: 32176270
Kidney Int. 2006 Jan;69(2):399-405
pubmed: 16408133
Kidney Int. 2023 May 24;:
pubmed: 37236423